Lead identification and optimization of novel collagenase inhibitors; pharmacophore and structure based studies
- PMID: 22553386
- PMCID: PMC3338973
- DOI: 10.6026/97320630008301
Lead identification and optimization of novel collagenase inhibitors; pharmacophore and structure based studies
Abstract
In this study, chemical feature based pharmacophore models of MMP-1, MMP-8 and MMP-13 inhibitors have been developed with the aid of HypoGen module within Catalyst program package. In MMP-1 and MMP-13, all the compounds in the training set mapped HBA and RA, while in MMP-8, the training set mapped HBA and HY. These features revealed responsibility for the high molecular bioactivity, and this is further used as a three dimensional query to screen the knowledge based designed molecules. These pharmacophore models for collagenases picked up some potent and novel inhibitors. Subsequently, docking studies were performed for the potent molecules and novel hits were suggested for further studies based on the docking score and active site interactions in MMP-1, MMP-8 and MMP-13.
Keywords: Collagenases; HypoGen; Induced Fit; Osteoarthritis; Pharmacophore; S1' loop.
Figures





Similar articles
-
Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.J Biomol Struct Dyn. 2019 Mar;37(4):944-965. doi: 10.1080/07391102.2018.1444510. Epub 2018 Mar 9. J Biomol Struct Dyn. 2019. PMID: 29475408
-
Screening for the selective inhibitors of MMP-9 from natural products based on pharmacophore modeling and molecular docking in combination with bioassay experiment, hybrid QM/MM calculation, and MD simulation.J Biomol Struct Dyn. 2019 Aug;37(12):3135-3149. doi: 10.1080/07391102.2018.1509019. Epub 2018 Sep 18. J Biomol Struct Dyn. 2019. PMID: 30079817
-
Multiple receptor-ligand based pharmacophore modeling and molecular docking to screen the selective inhibitors of matrix metalloproteinase-9 from natural products.J Comput Aided Mol Des. 2017 Jul;31(7):625-641. doi: 10.1007/s10822-017-0028-3. Epub 2017 Jun 16. J Comput Aided Mol Des. 2017. PMID: 28623487
-
Potent inhibitors precise to S1' loop of MMP-13, a crucial target for osteoarthritis.J Mol Graph Model. 2013 Jul;44:297-310. doi: 10.1016/j.jmgm.2013.06.005. Epub 2013 Jul 4. J Mol Graph Model. 2013. PMID: 23938376
-
Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.Curr Probl Cardiol. 2023 Jun;48(6):101660. doi: 10.1016/j.cpcardiol.2023.101660. Epub 2023 Feb 24. Curr Probl Cardiol. 2023. PMID: 36841313 Review.
Cited by
-
Combined structure- and ligand-based pharmacophore modeling and molecular dynamics simulation studies to identify selective inhibitors of MMP-8.J Mol Model. 2014 May;20(5):2191. doi: 10.1007/s00894-014-2191-y. Epub 2014 Apr 23. J Mol Model. 2014. PMID: 24756550
-
Prediction of MMP-9 inhibitory activity of N-hydroxy-α-phenylsulfonylacetamide derivatives by pharmacophore based modeling and 3-D QSAR studies.Porto Biomed J. 2018 Jul 3;3(1):e6. doi: 10.1016/j.pbj.0000000000000006. eCollection 2018 Aug. Porto Biomed J. 2018. PMID: 31595232 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Miscellaneous